PHATHOM PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.18 USD | +0.88% |
|
+2.34% | +0.55% |
| 07/03 | Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024 | |
| 07/03 | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Chart calendar Phathom Pharmaceuticals, Inc.
bac02051a7f34ade6bd6.8_49i52CvMGIWOZlVHYpH9XQnQ9z6GjQpnXWuvlvtqo.kKEF2PzB763-abILEzpqULaI9z4EuVy38gCA7IEY_MSbkHa_qMDKibkavw~68bc257babcd36d6c19c8aa0c6f6d1ee
Upcoming events on Phathom Pharmaceuticals, Inc.
Past events on Phathom Pharmaceuticals, Inc.
| 10/04/2024 07:00 pm | Needham Healthcare Conference |
| 07/03/2024 07:00 pm | Q4 2023 Earnings Call |
| 07/03/2024 06:30 pm | Q4 2023 Earnings Release |
| 08/02/2024 12:00 am | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 30/11/2023 02:45 am | Evercore ISI HealthCONx Conference |
| 16/11/2023 | Craig-Hallum Alpha Select Conference |
| 16/11/2023 12:55 am | Stifel Healthcare Conference |
| 14/11/2023 09:00 pm | Jefferies London Healthcare Conference |
| 09/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 08/11/2023 01:00 am | Guggenheim Securities Inflammation & Immunology Conference |
| 02/11/2023 08:30 pm | PHALCON-EE Phase 3 Trial Results Call |
| 14/09/2023 12:00 am | H.C. Wainwright Global Investment Conference |
| 12/09/2023 | Morgan Stanley Global Healthcare Conference |
| 10/08/2023 05:31 pm | Q2 2023 Earnings Release |
| 14/06/2023 08:30 pm | Goldman Sachs Global Healthcare Conference |
| 07/06/2023 11:00 pm | Jefferies Global Healthcare Conference |
| 25/05/2023 09:00 pm | Annual General Meeting |
| 10/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 06/05/2023 | Digestive Disease Week |
| 03/05/2023 12:00 am | H.C. Wainwright BioConnect Investor Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,68 0,44 55.12% | 43,3 |
|
EBITDA Million USD | Released Forecast Spread | -106 -118 10.05% | -125 -105 -19.44% | -135 -137 1.91% | -172 -165 -4.44% | -167 -162 -3.01% | -266 |
|
EBIT Million USD | Released Forecast Spread | -106 -84,9 -25.08% | -126 -105 -19.3% | -135 -139 2.93% | -172 -173 0.23% | -167 -152 -10.29% | -224 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -255 -112 -127.95% | -129 -108 -19.62% | -144 -143 -0.53% | -198 -196 -0.64% | -202 -186 -8.36% | -261 |
|
Net income Million USD | Released Forecast Spread | -255 -112 -127.95% | -129 -108 -19.66% | -144 -145 0.98% | -198 -196 -0.66% | -202 -186 -8.36% | -261 |
|
EPS USD | Released Forecast Spread | -11,4 -10,4 -9.38% | -3,88 -3,44 -12.79% | -3,89 -3,93 1.07% | -5,05 -5,01 -0.8% | -3,93 -3,79 -3.79% | -4,37 |
| Announcement Date | 19/03/20 | 30/03/21 | 01/03/22 | 28/02/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,16 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,68 0,38 79.85% | 2,17 | 6,01 | 12,0 | 22,9 | 34,5 |
|
EBIT Million USD | Released Forecast Spread | -33,0 -37,1 11.04% | -37,9 -35,3 -7.29% | -45,4 -39,6 -14.68% | -42,5 -46,4 8.31% | -46,6 -46,6 -0.08% | -30,1 -46,1 34.77% | -31,7 -38,8 18.24% | -35,7 -40,9 12.75% | -69,9 -57,8 -20.8% | -60,4 | -62,0 | -58,1 | -51,0 | -44,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -35,8 -35,0 -2.39% | -40,7 -37,7 -7.79% | -50,9 -42,7 -19.25% | -51,1 -49,6 -3.01% | -55,0 -51,2 -7.51% | -37,8 -50,5 25.07% | -41,0 -43,5 5.81% | -43,2 -48,1 10.09% | -79,6 -62,3 -27.75% | -64,5 | -64,8 | -62,0 | -57,0 | -53,7 |
|
Net income Million USD | Released Forecast Spread | -35,8 -35,0 -2.39% | -40,7 -37,7 -7.79% | -50,9 -42,7 -19.25% | -51,1 -49,6 -3.01% | -55,0 -51,2 -7.51% | -37,8 -50,5 25.07% | -41,0 -43,5 5.81% | -43,2 -48,1 10.09% | -79,6 -62,3 -27.75% | -64,5 | -64,8 | -62,0 | -57,0 | -53,7 |
|
EPS USD | Released Forecast Spread | -0,95 -1,00 4.62% | -1,07 -0,97 -10.54% | -1,33 -1,03 -29.13% | -1,32 -1,32 0.15% | -1,33 -1,34 1.04% | -0,89 -1,25 28.8% | -0,84 -0,98 14.11% | -0,76 -0,90 15.24% | -1,39 -1,11 -24.85% | -1,21 | -1,16 | -1,12 | -0,92 | -0,94 |
| Announcement Date | 01/03/22 | 10/05/22 | 02/08/22 | 08/11/22 | 28/02/23 | 10/05/23 | 10/08/23 | 09/11/23 | 07/03/24 | - | - | - | - | - |
| Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Phathom Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHAT Stock
- Calendar Phathom Pharmaceuticals, Inc.
